权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Michigan Institute for Clinical and Health Research (MICHR)

密歇根临床与健康研究所 (MICHR)

基本信息

批准号：
10116514
负责人：
Julie C Lumeng
金额：
$ 970.63万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2017
资助国家：
美国
起止时间：
2017-06-01 至 2023-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10116514
关键词：
Aging Area Basic Science Child Cities Clinical Clinical Research Clinical Trials Clinical and Translational Science Awards Collaborations Communities Competence Doctor of Philosophy Educational Curriculum Electronic Health Record Ensure Evaluation Faculty Foundations Funding Goals Grant Health Health Policy Human Informatics Institutes Institution Leadership Learning Module Longevity Measurable Methodology Methods Michigan Midwestern United States Multi-Institutional Clinical Trial NCI Scholars Program Network-based Phase Population Process Recording of previous events Research Research Methodology Research Personnel Research Training Resources Role Science Societies Special Population TNFSF15 gene Techniques Technology Testing Text Training Translational Research Translations Universities Work Workforce Development base clinical care cohort commercialization community based participatory research community engaged research community partnership design electronic consent experience high risk ideation improved innovation member mentoring community multimodality novel operation programs search engine success tool user-friendly

项目摘要

The Michigan Institute for Clinical & Health Research (MICHR) is a catalytic hub that significantly impacts the translation of investigative science into innovative improvements in clinical care and health policy. Our objective is to empower researchers and research communities within and outside the University of Michigan (U-M), creating a positive impact on health across local, regional, national, and global scales. We will achieve this objective through the following overarching specific aims: 1) Innovate and implement effective educational approaches to developing a skilled and diverse translational research workforce; 2) Catalyze effective research with community partnerships to accelerate the translation of breakthroughs that benefit society; 3) Promote clinical and translational research across translational phases and across the lifespan; 4) Advance research methods and processes that enable higher quality clinical and translational research; 5) Develop, demonstrate, and disseminate informatics innovations that facilitate the translation of biomedical discoveries to health impact. MICHR aspires to have a unique, substantial, measurable, and recognizable impact on U-M and the health of our communities. In order to achieve this with efficiency, we have critically evaluated pre- existing strengths and emerging opportunities across the institutional research landscape. MICHR will enhance and develop partnerships with major research and regulatory units on campus to develop an efficient pipeline that accelerates the translation and implementation of discoveries while also promoting cross-cutting signature initiatives that engage research and community members from all phases of translation.

密歇根州临床与健康研究所（MICHR）是一个催化中心，将调查科学转化为临床护理和卫生政策的创新改进。我们目标是授权密歇根大学内外的研究人员和研究团体 (U-M)，在地方、区域、国家和全球范围内对健康产生积极影响。我们将实现通过以下总体具体目标实现这一目标：1）创新和实施有效的教育培养熟练和多样化的翻译研究队伍的方法; 2）催化有效的研究与社区合作，加速转化有益于社会的突破; 3）促进跨转化阶段和整个生命周期的临床和转化研究; 4）高级研究方法和过程，使更高质量的临床和转化研究; 5）开发，展示和传播信息学创新，促进生物医学发现的翻译，健康影响。MICHR渴望对密歇根大学产生独特、实质性、可衡量和可识别的影响以及我们社区的健康。为了有效地实现这一目标，我们严格评估了预- 现有的优势和新兴的机会，在整个机构的研究景观。人权专员办事处将加强并与校园内的主要研究和监管单位建立伙伴关系，以开发高效的管道加快发现的转化和实施，同时促进跨领域签名这些举措吸引了来自翻译各个阶段的研究人员和社区成员的参与。